HIV subtypes and recombination strains-strategies for induction of immune responses in man-Reference-Cited by-同舟云学术

HIV subtypes and recombination strains-strategies for induction of immune responses in man

Published:2002-05 Issue:15 Volume:20 Page:1988-1993
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Wahren B,Ljungberg K,Rollman E,Levi M,Zuber B,Kjerrström Zuber A,Hinkula J,Leandersson A.-C,Calarota S,Hejdeman B,Bratt G,Sandström E

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference15 articles.

1. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection;Redfield;New Engl. J. Med.,1991

2. The Nordic VAC04 Study Group. Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial;Sandström;Lancet,1999

3. Cellular HIV-1 immune responses in natural infection and after genetic immunization;Calarota;Scand. J. Infect. Dis.,2001

4. Björndal Å. Biological determinants of HIV-1 infection: studies of viral evolution during disease progression in children and adults. Thesis, Karolinska Institute, 2000. ISBN 91-628-3996-9.

5. Gene inoculation generates immune responses against human immunodeficiency virus type 1;Wang;Proc. Natl. Acad. Sci. USA,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity;Vaccine;2011-01

2. HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development;International Reviews of Immunology;2009-01

3. A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice;Molecular Therapy;2007-09

4. Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization;Vaccine;2006-05

5. Molecular analysis and phylogenetic characterization of HIV in Iran;Journal of Medical Virology;2006